A clinical trial at UConn School of Medicine has confirmed that consuming a handful of walnuts daily can significantly enhance colonic health and contribute to cancer prevention. The study highlights the role of ellagitannins in walnuts, which convert in the gut to urolithin A—a potent anti-inflammatory agent—thereby reducing inflammatory markers. Conducted among patients aged 40-65 at increased risk for colon cancer, the findings showcase the low risks and potential health benefits of walnut consumption, encouraging daily inclusion of this nutrient-dense food in one's diet.
According to clinical trials, consuming walnuts daily can significantly improve colonic health and play a role in cancer prevention.
Ellagitannins in walnuts provide anti-inflammatory properties that the research team sees as beneficial during clinical trials.
Collection
[
|
...
]